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We describe the case of a 14-year-old boy who presented with a large, 17.6-cm retroperi-
toneal mass, along with multiple metastases, and was diagnosed with desmoplastic small
round cell tumor. After initial chemotherapy, he underwent gross total resection with a
positive margin. On postoperative radiation planning computed tomography, a 6.8-cm
heterogeneous mass was noted in the surgical bed. Given the tumor's aggressive nature
and positive surgical margins, there was real concern for recurrent disease. Further eval-
uation with magnetic resonance imaging elucidated that the mass consisted of simple fluid
and fat, without contrast enhancement, suggesting a postoperative fluid collection. He was
able to continue with adjuvant treatment as planned. This case example illustrates that
even large postoperative heterogeneous masses may still be related to postoperative fluid
collection in patients with aggressive tumor. However, it is important to rule out recurrent
disease before starting adjuvant therapy given improved outcomes with gross total
resection in desmoplastic small round cell tumor.
© 2016 the Authors. Published by Elsevier Inc. under copyright license from the University
of Washington. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Case presentation crossed midline, replaced the left kidney, displaced the aortaA 14-year-old boy with a previous history of acute myeloid
leukemia treated with chemotherapy and bone marrow
transplant presented with nausea, vomiting, and epigastric
pain. Initial workup revealed elevated liver function tests, a
left-sided abdominal mass, and multiple liver lesions on
abdominal ultrasound. Computed tomography (CT; Fig. 1,
Panel A) demonstrated a large, heterogeneous, left retroperi-
toneal mass measuring 17.1 cm  14.4 cm  17.6 cm thatlared that no competing i
Terezakis).
Elsevier Inc. under copy
se (http://creativecommotoward the right, displaced the pancreas superior and ante-
rior, displaced the spleen superiorly and laterally, and caused
mass effect on the stomach. Retroperitoneal lymphadenopa-
thy, multiple hypodense liver lesions in both the right and left
lobes with the largest measuring 6.0 cm in maximal dimen-
sion, multiple bilateral pulmonary nodules with the largest
measuring 2.3 cm inmaximal dimension, and sclerotic lesions
in bilateral iliac bones and the L4 vertebral body were also
noted. Liver core biopsy indicated desmoplastic small roundnterests exist.
right license from the University of Washington. This is an open
ns.org/licenses/by-nc-nd/4.0/).
Fig. 1 e CT abdomen and pelvis at initial presentation (A) and 6 weeks after surgical resection (B). Arrows indicate
preoperative and postoperative masses.
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itive for desmin, keratin AE1/2, CAM5.2, and WT-1 and nega-
tive for CD99, myogenin, and S100 protein.
He initiated treatment with a chemotherapy regimen
consisting of irinotecan, temozolomide, and temsirolimus,
followed by vincristine, doxorubicin, and cyclophosphamide
then ifosfamide and etoposide. A good response to chemo-
therapywas noted radiographically, with decreased size of the
primary mass to 14.1 cm  10.8 cm  13.1 cm, as well as
decreased size of the liver and lung lesions and retroperito-
neal lymphadenopathy. He then underwent resection of the
primary mass, which was found to involve the left kidney,
renal sinus, and perirenal soft tissue, with attachment to the
aorta. Pathology indicated a positive peripheral soft-tissue
margin but a negative hilar margin. On CT scan obtained six
weeks later (Fig. 1, Panel B) for postoperative radiation plan-
ning, a new 5.2 cm  5.6 cm  6.8 cm hypodense, heteroge-
neous mass was noted in the surgical bed, concerning for
recurrent disease.
Further evaluation withmagnetic resonance imaging (MRI)
of the abdomen and pelvis (Fig. 2) with and without gado-
linium and with T1-, T2-, and diffusion-weighted images
helped clarify that the mass consisted of simple fluid and fat,
with no internal enhancement on any phase of contrast
administration, suggesting postoperative seroma and/or
lymphocele and not recurrent disease. The patient then pro-
ceeded with postoperative radiation therapy to the whole
abdomen and pelvis to a total dose of 30 Gy (liver to only 24
Gy). He has since received additional chemotherapy and
haploidentical bone marrow transplant, with no evidence of
disease progression.Fig. 2 e MRI abdomen and pelvis, T1-weighted image after
administration of gadolinium, 7 weeks after surgical
resection. Arrow indicates postoperative mass.Discussion
The differential diagnosis of a postoperative surgical bed
lesion in the retroperitoneum is broad and includes lympho-
cele, seroma, hematoma, omental infarction, or recurrent
disease. DSRCT is a rare and highly aggressive tumor con-
taining desmoplastic stroma that affects primarily youngmen
(median age of 19 years), with a 3-year overall survival of 44%and 5-year overall survival of 15% based on a larger review of
66 patients treated atMemorial Sloan-Kettering Cancer Center
from 1972 to 2003 [1]. In the case of incomplete, margin-
positive surgical resections, locoregional recurrence is of
particular concern, even soon after surgery. Gross total
resection is essential for improved survival, as 3-year survival
is 58% in patients with gross total primary tumor resection
(>90% tumor resection), versus 0% in thosewith <90% primary
tumor resection [1]. Thus, it was particularly important in this
case to rule out local tumor recurrence before proceeding with
adjuvant radiation therapy.
DSRCT usually presents as a primary abdominal mass
along with multiple peritoneal and liver lesions and can also
metastasize to the lungs, bone marrow, and lymph nodes in
the neck, groin, and mediastinum [1e4]. Patients are
managed with aggressive multimodal therapy, including
neoadjuvant chemotherapy, maximal surgical debulking,
intraperitoneal chemotherapy in some cases, adjuvant
R a d i o l o g y C a s e R e p o r t s 1 1 ( 2 0 1 6 ) 2 4 8e2 5 0250whole abdominopelvic radiation therapy, and stem cell or
bone marrow transplant [1,4e8]. Patients receiving trimo-
dality therapy with chemotherapy, surgical resection, and
radiation therapy have improved 3-year survival (55%)
compared with patients who are not treated with all three
modalities (27%) [1]; however, outcomes remain poor despite
aggressive treatment. A more recent study from M.D.
Anderson does suggest potentially greater survival with
improved salvage therapies, with a median overall survival
of 60 months despite a median disease-free survival of
10 months [8].
Regarding imaging characteristics of DSRCT, CT findings
typically include heterogeneous enhancement with contrast,
cystic areas in approximately 50% of cases, and calcification
within soft-tissue lesions in approximately 20%-30% of cases
[2,9]. However, CT imaging is suboptimal for differentiating
DSRCT from other processes because of poor soft-tissue
contrast. On MRI, these tumors have heterogeneous hypo-
intense or isointense T1 and hyperintense T2 signal, as well as
heterogeneous contrast enhancement with gadolinium
[9e11]. This patient's MRI demonstrated no significant
enhancement with gadolinium within the lesion but rather
characteristics of simple fluid and fat. Thus, postoperative
seroma or lymphocele was favored, as opposed to tumor
recurrence. Although the role of PET-CT is notwell established
for evaluating DSRCT, reports have shown that many of these
tumors have intense FDG avidity [2,10,12], and thus PET-CT
could also have been considered in the evaluation of this
lesion. In the event that additional imaging could not defini-
tively rule out recurrence, biopsy or surgical evaluation would
have been considered, given the importance of maximal sur-
gical resection before proceeding with adjuvant therapy for
DSRCT.Conclusions
This case example illustrates that even large postoperative
heterogeneous masses may still be related to postoperative
fluid collection in patients with aggressive tumor and that it is
particularly important to investigate such findings before
proceeding with adjuvant therapy.r e f e r e n c e s
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